Tag: brand manufacturers
The Patent Cliff: How Generic Drugs Reshape Brand Manufacturer Economics
Explore how generic drugs trigger the 'patent cliff' for brand manufacturers, reshaping pharmaceutical economics. Learn about Hatch-Waxman, pay-for-delay tactics, and the $330B in annual savings driving industry change.
